OTCPK:CRRV.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. More Details


Snowflake Analysis

Weak fundamentals or lack of information.

Share Price & News

How has CVR Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CRRV.F's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-0.4%

CRRV.F

-1.7%

US Medical Equipment

-0.8%

US Market


1 Year Return

-66.3%

CRRV.F

16.5%

US Medical Equipment

13.8%

US Market

Return vs Industry: CRRV.F underperformed the US Medical Equipment industry which returned 16.5% over the past year.

Return vs Market: CRRV.F underperformed the US Market which returned 13.8% over the past year.


Shareholder returns

CRRV.FIndustryMarket
7 Day-0.4%-1.7%-0.8%
30 Day0%-3.3%-5.0%
90 Day-64.4%13.4%10.1%
1 Year-66.3%-66.3%17.5%16.5%16.4%13.8%
3 Year-95.0%-95.0%70.0%65.6%36.9%27.8%
5 Yearn/a139.5%121.3%85.0%64.2%

Price Volatility Vs. Market

How volatile is CVR Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is CVR Medical undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether CVR Medical is trading at an attractive price based on the cash flow it is expected to produce in the future. But as CVR Medical has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of CRRV.F's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through CVR Medical regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is CVR Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

24.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CVR Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of CRRV.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access CVR Medical's filings and announcementshere.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has CVR Medical performed over the past 5 years?

-30.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CRRV.F is currently unprofitable.

Growing Profit Margin: CRRV.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CRRV.F is unprofitable, and losses have increased over the past 5 years at a rate of 30.7% per year.

Accelerating Growth: Unable to compare CRRV.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CRRV.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.8%).


Return on Equity

High ROE: CRRV.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is CVR Medical's financial position?


Financial Position Analysis

Short Term Liabilities: CRRV.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: CRRV.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: CRRV.F has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: CRRV.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CRRV.F has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CRRV.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 35.7% each year


Next Steps

Dividend

What is CVR Medical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CRRV.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CRRV.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CRRV.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CRRV.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CRRV.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure


CEO

Paul Blunden

0.083

Tenure

US$94,760

Compensation

Dr. Paul S. Blunden, M.D., serves as Interim Chief Executive Officer and Chief Financial Officer at CVR Medical Corp. since August 2020. Dr. Blunden serves as President at CVR Medical Corp. since February ...


Leadership Team

NamePositionTenureCompensationOwnership
Paul Blunden
President0.083yrUS$94.76k0.79%
$ 14.9k
Erwin Wong
Strategic Financial Consultant2.33yrsUS$78.00kno data
Alan Langston
Vice President of Sales & Marketing3yrsno datano data
Philip Bendick
Medical Advisor & Independent Board Director0.58yrno datano data
Orville Day
Lead Physicistno datano datano data
Jeremy Poirier
Consultant3yrsno datano data

2.3yrs

Average Tenure

Experienced Management: CRRV.F's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Paul Blunden
President0.083yrUS$94.76k0.79%
$ 14.9k
Philip Bendick
Medical Advisor & Independent Board Director0.58yrno datano data
Joseph Lynch
Independent Director0.58yrno datano data

0.6yrs

Average Tenure

Experienced Board: CRRV.F's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

CVR Medical Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CVR Medical Corp.
  • Ticker: CRRV.F
  • Exchange: OTCPK
  • Founded: 1980
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$2.528m
  • Listing Market Cap: CA$1.885m
  • Shares outstanding: 126.38m
  • Website: https://cvrmed.com

Location

  • CVR Medical Corp.
  • 221 West Esplanade
  • Suite 409
  • North Vancouver
  • British Columbia
  • V7M 3J3
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
B3BNDB (Deutsche Boerse AG)YesCommon SharesDEEURSep 1988
CVMTSXV (TSX Venture Exchange)YesCommon SharesCACADSep 1988
CRRV.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDSep 1988
0UMWLSE (London Stock Exchange)YesCommon SharesGBCADSep 1988
B3BNMUN (Boerse Muenchen)YesCommon SharesDEEURSep 1988

Biography

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides ca ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/27 05:57
End of Day Share Price2020/09/25 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.